O

Omnicell
D

OMCL

29.220
USD
0.00
(0.00%)
Market Closed
Volume
0
EPS
5
Div Yield
-
P/E
64
Market Cap
1,368,770,109
Related Instruments
BAX
BAX
0.200
(0.65%)
30.810 USD
BDX
BDX
-0.095
(-0.06%)
172.150 USD
CAH
CAH
1.030
(0.64%)
162.410 USD
H
HSIC
0.540
(0.77%)
70.760 USD
MCK
MCK
-8.45
(-1.16%)
719.50 USD
MDT
MDT
0.680
(0.78%)
87.950 USD
ZBH
ZBH
0.920
(1.01%)
92.180 USD
More
News

Title: Omnicell

Sector: Healthcare
Industry: Health Information Services
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.